Nature de la demande
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
Vwpfh0ww1wM0cqrj
